Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Farah Al Qaraghuli"'
Autor:
Daniel Weiner, J. Robert Powell, J. Herbert Patterson, Rachel Tyson, Anil Gehi, Stephan Moll, Robyn Konicki, Farah Al Qaraghuli, Kristen B. Campbell, Angela D.M. Kashuba, Daniel Gonzalez
Publikováno v:
Journal of clinical pharmacology. 62(12)
Population pharmacokinetic (PK)/pharmacodynamic models are commonly used to inform drug dosing; however, often real-world patients are not well represented in the clinical trial population. We sought to determine how well dosing recommended in the ri
Autor:
Farah Al Qaraghuli, Ravindra Varma Alluri, Sophie M.A. Argon, Piyush Bajaj, Tashinga E. Bapiro, Abdul Basit, Andreas Brink, Tingting Cai, Jose Castro-Perez, Jae H. Chang, Eugene Chia-Te Chen, Marie Croft, Liam Evans, Raymond Evers, Robert S. Foti, Adrian J. Fretland, Christopher Gemski, Anima Ghosal, Jia Hao, Satyajeet Haridas, Simon Hauri, Nina Isoherranen, Wenying Jian, Kevin Johnson, Barry Jones, Robert S. Jones, Jan Felix Joseph, S. Cyrus Khojasteh, Yurong Lai, Hoa Le, Xiaomin Liang, Liming Liu, Filipe Lopes, Justin Q. Ly, Shuguang Ma, Roshini Markandu, Rosalinde Masereeuw, J. Eric McDuffie, Kaushik Mitra, Diana Montgomery, Alexandra L. Orton, Katie H. Owens, Axel Pähler, Maria Kristina Parr, Shefali Patel, Ichiko D. Petrie, Richard Phipps, Chandra Prakash, Bhagwat Prasad, Isabelle Ragueneau-Majlessi, Venkatesh Pilla Reddy, Ellen Riddle, Qian Ruan, Simone Schadt, Dhaval K. Shah, Julia Shanu-Wilson, Kelly MacLennan Staiger, Jonathan Steele, Manthena V.S. Varma, Matthew P. Wagoner, Naidong Weng, Stephen Wrigley, Caisheng Wu, Graeme C. Young, Jingjing Yu, Lushan Yu, Su Zeng, Haeyoung Zhang, Wanying Zhang, Andy Z.X. Zhu, Mingshe Zhu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32563bc881f8145ec2036a1b650e62de
https://doi.org/10.1016/b978-0-12-820018-6.09990-7
https://doi.org/10.1016/b978-0-12-820018-6.09990-7
Immuno-oncology (I-O) therapies exploit body's own immune system to fight cancer. These therapies include immune-checkpoint inhibitors, immune agonist antibodies, T-cell engaging bispecific molecules, CAR-T cells, and oncolytic viruses. While I-O the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbf3413adc8f1abb6b09ec4312fec780
https://doi.org/10.1016/b978-0-12-820018-6.00024-7
https://doi.org/10.1016/b978-0-12-820018-6.00024-7